1. A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. Issue 2 (30th November 2021) Authors: Cornell, Robert Frank; Baz, Rachid; Richter, Joshua R.; Rossi, Adriana; Vogl, Dan T.; Chen, Christine; Shustik, Chaim; Alvarez, Mariano J.; Shen, Yao; Unger, T. J.; Ben‐Shahar, Osnat; Wang, Hongwei; Baloglu, Erkan; Senapedis, William; Ma, Xiwen; Landesman, Yosef; Bai, Xiang; Bader, Justin; Xu, Ho... Journal: American journal of hematology Issue: Volume 97:Issue 2(2022) Page Start: E54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone. Issue 2 (28th December 2016) Authors: Muqbil, Irfana; Aboukameel, Amro; Elloul, Sivan; Carlson, Robert; Senapedis, William; Baloglu, Erkan; Kauffman, Michael; Shacham, Sharon; Bhutani, Divaya; Zonder, Jeffrey; Azmi, Asfar S.; Mohammad, Ramzi M. Journal: Cancer letters Issue: Volume 383:Issue 2(2016) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CBMT-04. INDUCING MITOCHONDRIAL OXIDATIVE STRESS AND TARGETING CELLULAR STRESS RESPONSE BY INHIBITION OF NAMPT, THE RATE LIMITING ENZYME IN THE NAD+ SALVAGE PATHWAY IN GLIOMA. (5th November 2018) Authors: Sharma, Pratibha; Senepides, William; Baloglu, Erkan; Puduvalli, Vinay Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cover Image, Volume 231, Number 12, December 2016. Issue 12 (December 2016) Authors: Taylor‐Kashton, Cheryl; Lichtensztejn, Daniel; Baloglu, Erkan; Senapedis, William; Shacham, Sharon; Kauffman, Michael G.; Kotb, Rami; Mai, Sabine Journal: Journal of cellular physiology Issue: Volume 231:Issue 12(2016:Dec.) Page Start: i Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-84. TARGETING THE SALVAGE PATHWAY OF NAD+ GENERATION IN GLIOMAS BY KPT-9274, A NOVEL DUAL INHIBITOR OF PAK4 AND NAMPT. Issue 11 (6th November 2017) Authors: Sharma, Pratibha; Kesanakurti, Divya; Wu, Pei-Jung; Xu, Jihong; Sampath, Deepa; Senapedis, William; Baloglu, Erkan; Puduvalli, Vinay K Journal: Neuro-oncology Issue: Volume 19:Issue 11(2017)supplement 6 Page Start: vi91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing. Issue 1 (22nd January 2015) Authors: Neggers, Jasper E.; Vercruysse, Thomas; Jacquemyn, Maarten; Vanstreels, Els; Baloglu, Erkan; Shacham, Sharon; Crochiere, Marsha; Landesman, Yosef; Daelemans, Dirk Journal: Chemistry & biology Issue: Volume 22:Issue 1(2015) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing. Issue 1 (22nd January 2015) Authors: Neggers, Jasper E.; Vercruysse, Thomas; Jacquemyn, Maarten; Vanstreels, Els; Baloglu, Erkan; Shacham, Sharon; Crochiere, Marsha; Landesman, Yosef; Daelemans, Dirk Journal: Chemistry & biology Issue: Volume 22:Issue 1(2015) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists. Issue 3 (3rd April 2015) Authors: Skepner, Jill; Trocha, Mark; Ramesh, Radha; Qu, Xiaoyan A.; Schmidt, Darby; Baloglu, Erkan; Lobera, Mercedes; Davis, Scott; Nolan, Michael A.; Carlson, Thaddeus J.; Hill, Jonathan; Ghosh, Shomir; Sundrud, Mark S.; Yang, Jianfei Journal: Immunology Issue: Volume 145:Issue 3(2015:Jul.) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P136 ELTANEXOR, AN EXPORTIN-1 INHIBITOR, RAPIDLY DECREASES INFLAMMATION AND IMPROVES OUTCOMES IN VITRO AND IN A DSS MODEL OF IBD. (7th February 2019) Authors: Stakenborg, Michelle; De Simone, Veronica; Widman, Douglas G; Gornisiewicz, Savanna; Tamir, Sharon; Baloglu, Erkan; Shacham, Sharon; Matteoli, Gianluca Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Issue 8 (10th May 2016) Authors: Jiang, Yan-Yi; Lin, De-Chen; Mayakonda, Anand; Hazawa, Masaharu; Ding, Ling-Wen; Chien, Wen-Wen; Xu, Liang; Chen, Ye; Xiao, Jin-Fen; Senapedis, William; Baloglu, Erkan; Kanojia, Deepika; Shang, Li; Xu, Xin; Yang, Henry; Tyner, Jeffrey W; Wang, Ming-Rong; Koeffler, H Phillip Journal: Gut Issue: Volume 66:Issue 8(2017) Page Start: 1358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗